Miranda Maria Hortencia, Nader-Macías María Elena Fátima
Reference Center for Lactobacilli, National Council for Scientific and Technical Research (CERELA-CONICET), Chacabuco 145, San Miguel de Tucumán (4000), Tucumán, Argentina.
FEMS Microbiol Lett. 2023 Jan 17;370. doi: 10.1093/femsle/fnad033.
As a first step for the use of probiotics in a formula for cattle, it is required to have available low-cost culture medium(s) and efficient production conditions for the growth of probiotic bacteria and high production of cell biomass. De Man-Rogosa-Sharpe medium, used frequently for lactic acid bacteria (LAB) contains adequate ingredients for their growth but is very expensive for industrial application. The nutrients required for LAB growth are strain-dependent. In this work, traditional culture media were evaluated omitting and/or modifying ingredients in their composition, as carbon or nitrogen source, on the basis of their low-cost industrial waste, to select those supporting the most efficient growth. The results showed that the formulation of culture media containing fructose (0.5%) and molasses (1.0%) was better for the growth and production of cell biomass for all the strains assayed, except Lactobacillus gasseri CRL1421 growing in 1.5% corn syrup. FM902 yeast extract at concentrations between 1.5% and 2.5% was the most adequate for most of the strains. The LAB grown in the designed media maintained the beneficial properties for which they selected. The use of the culture media designed to produce biomass decrease production costs, which is an important step for the feasible industrial production of probiotic pharmaceuticals.
作为在牛用配方中使用益生菌的第一步,需要有低成本的培养基以及有利于益生菌生长和大量产生细胞生物质的高效生产条件。常用于乳酸菌(LAB)的德氏乳杆菌-罗格斯-夏普培养基(De Man-Rogosa-Sharpe medium)含有适合其生长的成分,但对于工业应用来说成本非常高。乳酸菌生长所需的营养物质因菌株而异。在这项工作中,基于低成本的工业废料,对传统培养基的成分进行了省略和/或修改,作为碳源或氮源,以选择那些支持最有效生长的培养基。结果表明,对于所检测的所有菌株,含有果糖(0.5%)和糖蜜(1.0%)的培养基配方对细胞生物质的生长和产生效果更好,但加氏乳杆菌CRL1421在1.5%的玉米糖浆中生长。浓度在1.5%至2.5%之间的FM902酵母提取物对大多数菌株最为合适。在所设计的培养基中生长的乳酸菌保持了其被选择时的有益特性。使用设计用于生产生物质的培养基可降低生产成本,这是益生菌药物实现工业化生产的重要一步。